SQA Regulatory Submissions and Compliance 2 — Questions and Answers
Question 1: What is the purpose of the OECD Test Guidelines Programme in the context of GLP?
- To provide internationally harmonized methods for conducting nonclinical safety tests accepted by all OECD member countries (Correct answer)
- To replace GLP regulations in all OECD countries
- To set maximum residue limits for pesticides in food
- To establish clinical trial design standards
Correct answer: To provide internationally harmonized methods for conducting nonclinical safety tests accepted by all OECD member countries
OECD Test Guidelines provide standardized nonclinical testing methods recognized internationally, enabling mutual acceptance of GLP study data.
Question 2: Which element is required in a GLP compliance statement submitted with a regulatory application?
- A statement that the study was conducted in accordance with GLP regulations, signed by the Study Director (Correct answer)
- Signature of the FDA reviewer
- Sponsor's financial disclosure statement
- IRB approval documentation
Correct answer: A statement that the study was conducted in accordance with GLP regulations, signed by the Study Director
A signed GLP compliance statement by the Study Director is required in regulatory submissions to certify that the study met GLP standards.
Question 3: Under the OECD Principles of GLP, which document must be referenced when a nonclinical safety study uses an OECD Test Guideline method?
- The specific OECD Test Guideline number and version must be cited in the protocol and final report (Correct answer)
- Only the sponsor's internal SOP for the method needs to be cited
- No citation is required if the method is widely known
- The original literature source for the method must be cited instead of the OECD guideline
Correct answer: The specific OECD Test Guideline number and version must be cited in the protocol and final report
The protocol and final report must cite the specific OECD Test Guideline used, including its number and version, to ensure traceability and regulatory acceptance.
Question 4: What is the significance of the OECD Mutual Acceptance of Data (MAD) framework for US sponsors submitting studies internationally?
- Studies conducted under GLP in one OECD member country are accepted by other member countries, eliminating the need to duplicate studies (Correct answer)
- US GLP studies are automatically accepted by all countries globally, not just OECD members
- MAD applies only to agricultural chemical safety studies, not pharmaceutical studies
- MAD requires re-inspection of the test facility by each receiving country's regulatory agency
Correct answer: Studies conducted under GLP in one OECD member country are accepted by other member countries, eliminating the need to duplicate studies
OECD MAD allows GLP-compliant studies from one member country to be submitted to regulatory authorities in other member countries without requiring study repetition.
Question 5: Which FDA guidance document provides the agency's current thinking on GLP regulations for nonclinical laboratory studies?
- FDA's Bioresearch Monitoring compliance program guidance manuals for GLP inspections (Correct answer)
- ICH E6(R2) Good Clinical Practice guideline
- FDA's 21 CFR Part 11 electronic records guidance
- FDA's process validation guidance for pharmaceutical manufacturing
Correct answer: FDA's Bioresearch Monitoring compliance program guidance manuals for GLP inspections
FDA BIMO compliance program guidance manuals describe how FDA GLP inspectors assess compliance and what areas they focus on.
Question 6: When a GLP study is conducted at multiple test sites (multisite study), what additional GLP requirements apply?
- Each site must have a Principal Investigator, the Study Director retains overall responsibility, and each site's activities must be covered by the protocol (Correct answer)
- Each site must have its own Study Director
- A separate QAU must be established at each site independently
- The sponsor must conduct GLP inspections at each site before the study begins
Correct answer: Each site must have a Principal Investigator, the Study Director retains overall responsibility, and each site's activities must be covered by the protocol
Multisite GLP studies require a Principal Investigator at each site, a single Study Director with overall responsibility, and protocol coverage of all site activities.
SQA Regulatory Submissions and Compliance 2
What is the purpose of the OECD Test Guidelines Programme in the context of GLP?